Experimental human sepsis models

Drug Discovery Today: Disease Models

Volumn 9, Issue 1, 2012, Pages

  Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 7; CATECHOLAMINE; GLUTAMINE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIOTHYRONINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; PREDNISOLONE; THROMBIN; THYROTROPIN; THYROXINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL CELL WALL; COMPUTER MODEL; CYTOKINE PRODUCTION; ENDOTOXEMIA; FIBRINOLYSIS; GLUCOGENESIS; GLUCONEOGENESIS; HEART INDEX; HEART RATE; HEMODYNAMICS; HUMAN; HYPERCORTISOLISM; INFLAMMATION; LEUKOCYTE COUNT; LEUKOPENIA; LUNG FUNCTION; MEAN ARTERIAL PRESSURE; NEUROENDOCRINE SYSTEM; PROTEIN EXPRESSION; SEPSIS;

EID: 84862205531     PISSN: None     EISSN: 17406757     Source Type: Journal    
DOI: 10.1016/j.ddmod.2011.07.007     Document Type: Review

References (40)

1. Lowry, S.F. (2005) Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock 24 (Suppl. 1), 94-100
2. van der Poll, T. and Opal, S.M. (2008) Host-pathogen interactions in sepsis. Lancet Infect. Dis. 8, 32-43
3. Hochstein, H.D. et al. (1983) The processing and collaborative assay of a reference endotoxin. J. Biol. Stand. 11, 251-260 (Pubitemid 14227319)
4. Suffredini, A.F. et al. (1989) The cardiovascular response of normal humans to the administration of endotoxin. N. Engl. J. Med. 321, 280-287 (Pubitemid 19193802)
5. Engelhardt, R. et al. (1991) Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients. Cancer Res. 51, 2524-2530
6. Taveira da Silva, A.M. et al. (1993) Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N. Engl. J. Med. 328, 1457-1460
7. Michie, H.R. et al. (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318, 1481-1486
8. von der Mohlen, M.A. et al. (1996) Release of bactericidal/ permeabilityincreasing protein in experimental endotoxemia and clinical sepsis. Role of tumor necrosis factor. J. Immunol. 156, 4969-4973 (Pubitemid 26174487)
9. Calvano, S.E. et al. (2005) A network-based analysis of systemic inflammation in humans. Nature 437, 1032-1037 (Pubitemid 41486985)
10. Granowitz, E.V. et al. (1993) Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J. Immunol. 151, 1637-1645 (Pubitemid 23219302)
11. de Vos, A.F. et al. (2009) In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands. J. Immunol. 183, 533-542
12. van't Veer, C. et al. (2007) Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J. Immunol. 179, 7110-7120
13. van der Poll, T. et al. (1996) Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin. J. Infect. Dis. 174, 1356-1360 (Pubitemid 26393922)
14. Draisma, A. et al. (2009) Development of endotoxin tolerance in humans in vivo. Crit. Care Med. 37, 1261-1267
15. Mayr, F.B. and Jilma, B. (2006) Coagulation interventions in experimental human endotoxemia. Transl. Res. 148, 263-271 (Pubitemid 44634300)
16. Aras, O. et al. (2004) Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 103, 4545-4553 (Pubitemid 38745982)
17. Franco, R.F. et al. (2000) The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood 96, 554-559 (Pubitemid 30463375)
18. Suffredini, A.F. et al. (1989) Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N. Engl. J. Med. 320, 1165-1172 (Pubitemid 19124297)
19. van Deventer, S.J. et al. (1990) Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76, 2520-2526
20. van der Poll, T. et al. (1995) Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man. J. Clin. Endocrinol. Metab. 80, 1341-1346
21. Fong, Y.M. et al. (1990) The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J. Clin. Invest. 85, 1896-1904
22. Fong, Y. et al. (1994) Whole body and splanchnic leucine, phenylalanine, and glucose kinetics during endotoxemia in humans. Am. J. Physiol. 266 (Pt 2), R419-R425
23. Verbon, A. et al. (2001) IC14, an anti-CD14 antibody, inhibits endotoxinmediated symptoms and inflammatory responses in humans. J. Immunol. 166, 3599-3605 (Pubitemid 33117366)
24. Lynn, M. et al. (2003) Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia. J. Infect. Dis. 187, 631-639 (Pubitemid 36250027)
25. van der Poll, T. et al. (1997) Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood 89, 3727-3734 (Pubitemid 27227096)
26. Pajkrt, D. et al. (1997) Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. J. Immunol. 158, 3971-3977 (Pubitemid 127488758)
27. Pajkrt, D. et al. (1997) Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia. Blood 89, 2701-2705 (Pubitemid 27172554)
28. Lauw, F.N. et al. (2000) Proinflammatory effects of IL-10 during human endotoxemia. J. Immunol. 165, 2783-2789 (Pubitemid 30660729)
29. Pajkrt, D. et al. (1997) Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood 90, 1415-1424 (Pubitemid 27356396)
30. Barber, A.E. et al. (1993) Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J. Immunol. 150, 1999-2006 (Pubitemid 23129678)
31. van der Poll, T. et al. (1996) Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia - a clinical research center study. J. Clin. Endocrinol. Metab. 81, 3604-3606 (Pubitemid 26339923)
32. de Kruif, M.D. et al. (2007) Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia. J. Immunol. 178, 1845-1851 (Pubitemid 46154657)
33. van der Poll, T. et al. (1996) Epinephrine inhibits tumor necrosis factoralpha and potentiates interleukin 10 production during human endotoxemia. J. Clin. Invest. 97, 713-719 (Pubitemid 26057090)
34. van der Poll, T. et al. (1997) Epinephrine exerts anticoagulant effects during human endotoxemia. J. Exp. Med. 185, 1143-1148 (Pubitemid 27136807)
35. Stegenga, M.E. et al. (2008) Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood 112, 82-89
36. Wittebole, X. et al. (2007) Nicotine exposure alters in vivo human responses to endotoxin. Clin. Exp. Immunol. 147, 28-34 (Pubitemid 44915552)
37. Kox, M. et al. (2011) Effects of the alpha7 nAChR agonist GTS-21 on the innate immune response in humans. Shock 36, 5-11
38. Dorresteijn, M.J. et al. (2010) C1-esterase inhibitor attenuates the inflammatory response during human endotoxemia. Crit. Care Med. 38, 2139-2145
39. Clermont, G. et al. (2004) In silico design of clinical trials: a method coming of age. Crit. Care Med. 32, 2061-2070 (Pubitemid 39372540)
40. Vodovotz, Y. et al. (2004) Mathematical models of the acute inflammatory response. Curr. Opin. Crit. Care 10, 383-390 (Pubitemid 39313509)